Page last updated: 2024-08-25

rosiglitazone and 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one

rosiglitazone has been researched along with 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chien, S; Forman, BM; Formentin, K; Lee, TS; Liu, Y; Rannou, F; Shyy, JY; Wang, N; Yuan, X; Zeng, L; Zhu, Y1

Other Studies

1 other study(ies) available for rosiglitazone and 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one

ArticleYear
Laminar flow activates peroxisome proliferator-activated receptor-gamma in vascular endothelial cells.
    Circulation, 2004, Aug-31, Volume: 110, Issue:9

    Topics: Animals; Cattle; CD36 Antigens; Cells, Cultured; Chlorocebus aethiops; Cytochrome P-450 Enzyme System; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Humans; Inflammation; Naphthalenes; NF-kappa B; Phospholipases A; Phospholipases A2; PPAR gamma; Pyrones; Reverse Transcriptase Polymerase Chain Reaction; Rheology; RNA, Messenger; RNA, Small Interfering; Rosiglitazone; Stress, Mechanical; Thiazolidinediones; Transcription, Genetic; Transfection

2004